(WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct Targeted Methylation ...

In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

According to Mordor Intelligence, the blood screening market is valued at USD 3.24 billion in 2025 and is forecast to reach ...

Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...